Prana Thoracic, a Houston, TX-based medtech startup, received an investment from cultivate(MD).
In addition to the investment from cultivate(MD), this fundraising round was supported by new investors GenHenn Capital, and Houston Angel Network, with participation from prior lead investor New World Angels. Existing investors include Johnson & Johnson Development Corp, Texas Medical Center Venture Fund, and the Cancer Prevention & Research Institute of Texas (CPRIT).
The amount of the deal was not disclosed.
The company intends to use the funds to accelerate its product development and advance its clinical and regulatory milestones.
Led by CEO Joanna Nathan, Prana Thoracic offers the Prana System, which has been designed to enable image-guided, minimally invasive surgery, conserving healthy tissue and driving personalized treatment plans in a range of conditions including lung cancer.